Global Fund to Fight AIDS Tuberculosis and Malaria

Analysis

Global Fund to Fight AIDS Tuberculosis and Malaria is a registered charity in United States, based in Switzerland. It received its IRS tax-exemption ruling in November 2002, 24 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Global Fund to Fight AIDS Tuberculosis and Malaria reported income of $6.31bn and spending of $5.03bn, leaving 20% of income unspent that year. Across the 5 years on record, from December 2019 to December 2023, income grew from $3.95bn to $6.31bn (+60%), an average of +12% a year. The sharpest change came in the year to December 2022, when income rose by 79%. Over the whole period it spent 90% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Global Fund to Fight AIDS Tuberculosis and Malaria sits at the 100th percentile: it is one of the largest 1% in its cause. Against every charity in United States with reported income it ranks in the 100th percentile. Charities of a similar size with the same main cause include Adventist Health System Sunbelt Inc ($6.25bn), BJC Health System ($6.74bn) and Ucare Minnesota ($6.16bn).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 98% of the total. Compensation of current officers, directors and key employees was $9.2m (0.2% of expenses). Other salaries and wages came to $146.1m. At year end it held assets of $9.26bn against liabilities of $3.06bn, net assets of $6.21bn.